Hologic Non Operating Income Net Other from 2010 to 2026

HOLX Stock  USD 75.49  0.03  0.04%   
Hologic Non Operating Income Net Other yearly trend continues to be fairly stable with very little volatility. Non Operating Income Net Other is likely to outpace its year average in 2026. During the period from 2010 to 2026, Hologic Non Operating Income Net Other regression line of annual values had r-squared of  0.42 and arithmetic mean of  11,438,897. View All Fundamentals
 
Non Operating Income Net Other  
First Reported
2009-06-30
Previous Quarter
34.4 M
Current Value
38.4 M
Quarterly Volatility
15.1 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Hologic financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Hologic's main balance sheet or income statement drivers, such as Depreciation And Amortization of 362 M, Interest Expense of 74 M or Total Revenue of 5 B, as well as many indicators such as Price To Sales Ratio of 5.0, Dividend Yield of 0.0 or PTB Ratio of 3.56. Hologic financial statements analysis is a perfect complement when working with Hologic Valuation or Volatility modules.
  
Build AI portfolio with Hologic Stock
Check out the analysis of Hologic Correlation against competitors.
For more information on how to buy Hologic Stock please use our How to Invest in Hologic guide.
The evolution of Non Operating Income Net Other for Hologic provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Hologic compares to historical norms and industry peers.

Latest Hologic's Non Operating Income Net Other Growth Pattern

Below is the plot of the Non Operating Income Net Other of Hologic over the last few years. It is Hologic's Non Operating Income Net Other historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Hologic's overall financial position and show how it may be relating to other accounts over time.
Non Operating Income Net Other10 Years Trend
Slightly volatile
   Non Operating Income Net Other   
       Timeline  

Hologic Non Operating Income Net Other Regression Statistics

Arithmetic Mean11,438,897
Geometric Mean21,057,448
Coefficient Of Variation297.50
Mean Deviation26,108,151
Median13,400,000
Standard Deviation34,030,314
Sample Variance1158.1T
Range124.4M
R-Value0.65
Mean Square Error713.1T
R-Squared0.42
Significance0
Slope4,381,679
Total Sum of Squares18529T

Hologic Non Operating Income Net Other History

202652 M
202549.6 M
202143.1 M
2020-25.6 M
201813.4 M
2017-32 M
201613.5 M

About Hologic Financial Statements

Hologic investors use historical fundamental indicators, such as Hologic's Non Operating Income Net Other, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Hologic. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Non Operating Income Net Other49.6 M52 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Hologic Stock Analysis

When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.